Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
A bill to amend the Internal Revenue Code of 1986 to make permanent the reduced recognition period for built-in gains for S corporations.
Client: MEDIMMUNE LLC · Firm: MEDIMMUNE, LLC.
H.R. 2405/S. 1855 - Pandemic and All-Hazards Preparedness Act Reauthorization, provisions relating to pandemic influenza vaccine developmentPrematurity Research Expansion and Education for Mothers Who Deliver Infants Early Reauthorization Act, provisions relating to patient safety study and report A bill to amend the Internal Revenue Code of 1986 to include vaccines against seasonal influenza within the definition of taxable vaccines Issues related to Medicaid coverage and reimbursement of biologics; securing the pharmaceutical distribution system through a federal traceability standard; reimbursement of vaccines and related services; implementation of H.R. 3590/Pub. L. No. 111-148, the Patient Protection and Affordable Care Act; biologics data exclusivity; clinical trial and testing issues; and, debt and deficit reduction proposals on Medicaid federal funding, Medicaid rebates, and Medicare Part D rebates. Issues related to Medicaid coverage and reimbursement of respiratory syncytial virus (RSV) prophylaxis and federal quality strategies for prevention of RSV. Proposed FY2014 Budgets Congressional and White House budgets--health care related provisions.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
MEDIMMUNE LLC via MEDIMMUNE, LLC.
2013 · first_quarter · Q1
H.R. 2405/S. 1855 - Pandemic and All-Hazards Preparedness Act Reauthorization, provisions relating to pandemic influenza vaccine developmentPrematurity Research Expansion and Education for Mothers Who Deliver Infants Early Reauthorization Act, provisions relating to patient safety study and report A bill to amend the Internal Revenue Code of 1986 to include vaccines against seasonal influenza within the definition of taxable vaccines Issues related to Medicaid coverage and reimbursement of biologics; securing the pharmaceutical distribution system through a federal traceability standard; reimbursement of vaccines and related services; implementation of H.R. 3590/Pub. L. No. 111-148, the Patient Protection and Affordable Care Act; biologics data exclusivity; clinical trial and testing issues; and, debt and deficit reduction proposals on Medicaid federal funding, Medicaid rebates, and Medicare Part D rebates. Issues related to Medicaid coverage and reimbursement of respiratory syncytial virus (RSV) prophylaxis and federal quality strategies for prevention of RSV. Proposed FY2014 Budgets Congressional and White House budgets--health care related provisions.
Source: Senate LDA
Pandemic and All-Hazards Preparedness Reauthorization Act of 2011
Client: MEDIMMUNE LLC · Firm: MEDIMMUNE, LLC.
H.R. 2405/S. 1855 - Pandemic and All-Hazards Preparedness Act Reauthorization, provisions relating to pandemic influenza vaccine developmentPrematurity Research Expansion and Education for Mothers Who Deliver Infants Early Reauthorization Act, provisions relating to patient safety study and report A bill to amend the Internal Revenue Code of 1986 to include vaccines against seasonal influenza within the definition of taxable vaccines Issues related to Medicaid coverage and reimbursement of biologics; securing the pharmaceutical distribution system through a federal traceability standard; reimbursement of vaccines and related services; implementation of H.R. 3590/Pub. L. No. 111-148, the Patient Protection and Affordable Care Act; biologics data exclusivity; clinical trial and testing issues; and, debt and deficit reduction proposals on Medicaid federal funding, Medicaid rebates, and Medicare Part D rebates. Issues related to Medicaid coverage and reimbursement of respiratory syncytial virus (RSV) prophylaxis and federal quality strategies for prevention of RSV. Proposed FY2014 Budgets Congressional and White House budgets--health care related provisions.
H.R. 2405/S. 1855 - Pandemic and All-Hazards Preparedness Act Reauthorization, provisions relating to pandemic influenza vaccine developmentPrematurity Research Expansion and Education for Mothers Who Deliver Infants Early Reauthorization Act, provisions relating to patient safety study and report A bill to amend the Internal Revenue Code of 1986 to include vaccines against seasonal influenza within the definition of taxable vaccines Issues related to Medicaid coverage and reimbursement of biologics; securing the pharmaceutical distribution system through a federal traceability standard; reimbursement of vaccines and related services; implementation of H.R. 3590/Pub. L. No. 111-148, the Patient Protection and Affordable Care Act; biologics data exclusivity; clinical trial and testing issues; and, debt and deficit reduction proposals on Medicaid federal funding, Medicaid rebates, and Medicare Part D rebates. Issues related to Medicaid coverage and reimbursement of respiratory syncytial virus (RSV) prophylaxis and federal quality strategies for prevention of RSV. Proposed FY2014 Budgets Congressional and White House budgets--health care related provisions.
Pandemic and All-Hazards Preparedness Reauthorization Act of 2011
Client: MEDIMMUNE LLC · Firm: MEDIMMUNE, LLC.
H.R. 2405/S. 1855 - Pandemic and All-Hazards Preparedness Act Reauthorization, provisions relating to pandemic influenza vaccine development H.R. 2679/S. 1440 - Prematurity Research Expansion and Education for Mothers Who Deliver Infants Early Reauthorization Act, provisions relating to patient safety study and report H.R. 6687/S. 3176 A bill to amend the Internal Revenue Code of 1986 to include vaccines against seasonal influenza within the definition of taxable vaccines Issues related to Medicaid coverage and reimbursement of biologics; securing the pharmaceutical distribution system through a federal traceability standard; reimbursement of vaccines and related services; implementation of H.R. 3590/Pub. L. No. 111-148, the Patient Protection and Affordable Care Act; biologics data exclusivity; clinical trial and testing issues; and, debt and deficit reduction proposals on Medicaid federal funding, Medicaid rebates, and Medicare Part D rebates.
Pandemic and All-Hazards Preparedness Reauthorization Act of 2011
Client: MEDIMMUNE LLC · Firm: MEDIMMUNE, LLC.
H.R. 2405/S. 1855 - Pandemic and All-Hazards Preparedness Act Reauthorization, provisions relating to pandemic influenza vaccine development H.R. 2679 - Prematurity Research Expansion and Education for Mothers Who Deliver Infants Early Reauthorization Act, provisions relating to patient safety study and report Issues related to Medicaid coverage and reimbursement of biologics; securing the pharmaceutical distribution system; enactment of federal excise tax for seasonal influenza vaccines and coverage of quadrivalent influenza vaccines under the Vaccine Injury Compensation Program; reimbursement of vaccines and related services; implementation of H.R. 3590/Pub. L. No. 111-148, the Patient Protection and Affordable Care Act; biologics data exclusivity; clinical trial and testing issues; and, debt and deficit reduction proposals on Medicaid federal funding, Medicaid rebates, and Medicare Part D rebates.
Pandemic and All-Hazards Preparedness Reauthorization Act of 2011
Client: MEDIMMUNE LLC · Firm: MEDIMMUNE, LLC.
H.R. 2055/Pub. L. No. 112-74 - Consolidated Appropriations Act, 2012, provisions relating to funding for Health and Human Services H.R. 2405/S. 1855 - Pandemic and All-Hazards Preparedness Act Reauthorization, provisions relating to pandemic influenza vaccine development H.R. 4274 - BPCA and PREA Reauthorization Act of 2012 H.R. 2679 - Prematurity Research Expansion and Education for Mothers Who Deliver Infants Early Reauthorization Act, provisions relating to patient safety study and report Issues related to development of legislation reauthorizing the Prescription Drug User Fee Act (PDUFA), including issues relating to approval of biologics, pediatric research incentives, supply chain integrity, drug shortages, and antibiotic incentives; CDC Burden of Disease Study on Respiratory Syncytial Virus (RSV), including RSV prophylaxis; implementation of H.R. 3590/Pub. L. No. 111-148, the Patient Protection and Affordable Care Act; reimbursement of vaccines and related services; Medicaid coverage and reimbursement; biologics data exclusivity; and, debt and deficit reduction proposals on Medicaid federal funding, Medicaid rebates, and Medicare Part D rebates
Pandemic and All-Hazards Preparedness Reauthorization Act of 2011
Client: MEDIMMUNE LLC · Firm: MEDIMMUNE, LLC.
S. 3187/Pub. L. No. 112-144 - Food and Drug Administration Safety and Innovation Act H.R. 2405/S. 1855 - Pandemic and All-Hazards Preparedness Act Reauthorization, provisions relating to pandemic influenza vaccine development H.R. 2679 - Prematurity Research Expansion and Education for Mothers Who Deliver Infants Early Reauthorization Act, provisions relating to patient safety study and report Issues related to securing the pharmaceutical distribution system; enactment of federal excise tax for seasonal influenza vaccines and coverage of quadrivalent influenza vaccines under the Vaccine Injury Compensation Program; reimbursement of vaccines and related services; implementation of H.R. 3590/Pub. L. No. 111-148, the Patient Protection and Affordable Care Act; Medicaid coverage and reimbursement; biologics data exclusivity; and, debt and deficit reduction proposals on Medicaid federal funding, Medicaid rebates, and Medicare Part D rebates.
H.R. 2405/S. 1855 - Pandemic and All-Hazards Preparedness Act Reauthorization, provisions relating to pandemic influenza vaccine development H.R. 2679 - Prematurity Research Expansion and Education for Mothers Who Deliver Infants Early Reauthorization Act, provisions relating to patient safety study and report Issues related to Medicaid coverage and reimbursement of biologics; securing the pharmaceutical distribution system; enactment of federal excise tax for seasonal influenza vaccines and coverage of quadrivalent influenza vaccines under the Vaccine Injury Compensation Program; reimbursement of vaccines and related services; implementation of H.R. 3590/Pub. L. No. 111-148, the Patient Protection and Affordable Care Act; biologics data exclusivity; clinical trial and testing issues; and, debt and deficit reduction proposals on Medicaid federal funding, Medicaid rebates, and Medicare Part D rebates.
H.R. 2405/S. 1855 - Pandemic and All-Hazards Preparedness Act Reauthorization, provisions relating to pandemic influenza vaccine development H.R. 2679/S. 1440 - Prematurity Research Expansion and Education for Mothers Who Deliver Infants Early Reauthorization Act, provisions relating to patient safety study and report H.R. 6687/S. 3176 A bill to amend the Internal Revenue Code of 1986 to include vaccines against seasonal influenza within the definition of taxable vaccines Issues related to Medicaid coverage and reimbursement of biologics; securing the pharmaceutical distribution system through a federal traceability standard; reimbursement of vaccines and related services; implementation of H.R. 3590/Pub. L. No. 111-148, the Patient Protection and Affordable Care Act; biologics data exclusivity; clinical trial and testing issues; and, debt and deficit reduction proposals on Medicaid federal funding, Medicaid rebates, and Medicare Part D rebates.
H.R. 2055/Pub. L. No. 112-74 - Consolidated Appropriations Act, 2012, provisions relating to funding for Health and Human Services H.R. 2405/S. 1855 - Pandemic and All-Hazards Preparedness Act Reauthorization, provisions relating to pandemic influenza vaccine development H.R. 4274 - BPCA and PREA Reauthorization Act of 2012 H.R. 2679 - Prematurity Research Expansion and Education for Mothers Who Deliver Infants Early Reauthorization Act, provisions relating to patient safety study and report Issues related to development of legislation reauthorizing the Prescription Drug User Fee Act (PDUFA), including issues relating to approval of biologics, pediatric research incentives, supply chain integrity, drug shortages, and antibiotic incentives; CDC Burden of Disease Study on Respiratory Syncytial Virus (RSV), including RSV prophylaxis; implementation of H.R. 3590/Pub. L. No. 111-148, the Patient Protection and Affordable Care Act; reimbursement of vaccines and related services; Medicaid coverage and reimbursement; biologics data exclusivity; and, debt and deficit reduction proposals on Medicaid federal funding, Medicaid rebates, and Medicare Part D rebates
S. 3187/Pub. L. No. 112-144 - Food and Drug Administration Safety and Innovation Act H.R. 2405/S. 1855 - Pandemic and All-Hazards Preparedness Act Reauthorization, provisions relating to pandemic influenza vaccine development H.R. 2679 - Prematurity Research Expansion and Education for Mothers Who Deliver Infants Early Reauthorization Act, provisions relating to patient safety study and report Issues related to securing the pharmaceutical distribution system; enactment of federal excise tax for seasonal influenza vaccines and coverage of quadrivalent influenza vaccines under the Vaccine Injury Compensation Program; reimbursement of vaccines and related services; implementation of H.R. 3590/Pub. L. No. 111-148, the Patient Protection and Affordable Care Act; Medicaid coverage and reimbursement; biologics data exclusivity; and, debt and deficit reduction proposals on Medicaid federal funding, Medicaid rebates, and Medicare Part D rebates.
S. 3187/Pub. L. No. 112-144 - Food and Drug Administration Safety and Innovation Act H.R. 2405/S. 1855 - Pandemic and All-Hazards Preparedness Act Reauthorization, provisions relating to pandemic influenza vaccine development H.R. 2679 - Prematurity Research Expansion and Education for Mothers Who Deliver Infants Early Reauthorization Act, provisions relating to patient safety study and report Issues related to securing the pharmaceutical distribution system; enactment of federal excise tax for seasonal influenza vaccines and coverage of quadrivalent influenza vaccines under the Vaccine Injury Compensation Program; reimbursement of vaccines and related services; implementation of H.R. 3590/Pub. L. No. 111-148, the Patient Protection and Affordable Care Act; Medicaid coverage and reimbursement; biologics data exclusivity; and, debt and deficit reduction proposals on Medicaid federal funding, Medicaid rebates, and Medicare Part D rebates.
H.R. 2405/S. 1855 - Pandemic and All-Hazards Preparedness Act Reauthorization, provisions relating to pandemic influenza vaccine development H.R. 2679/S. 1440 - Prematurity Research Expansion and Education for Mothers Who Deliver Infants Early Reauthorization Act, provisions relating to patient safety study and report H.R. 6687/S. 3176 A bill to amend the Internal Revenue Code of 1986 to include vaccines against seasonal influenza within the definition of taxable vaccines Issues related to Medicaid coverage and reimbursement of biologics; securing the pharmaceutical distribution system through a federal traceability standard; reimbursement of vaccines and related services; implementation of H.R. 3590/Pub. L. No. 111-148, the Patient Protection and Affordable Care Act; biologics data exclusivity; clinical trial and testing issues; and, debt and deficit reduction proposals on Medicaid federal funding, Medicaid rebates, and Medicare Part D rebates.
H.R. 2405/S. 1855 - Pandemic and All-Hazards Preparedness Act Reauthorization, provisions relating to pandemic influenza vaccine development H.R. 2679 - Prematurity Research Expansion and Education for Mothers Who Deliver Infants Early Reauthorization Act, provisions relating to patient safety study and report Issues related to Medicaid coverage and reimbursement of biologics; securing the pharmaceutical distribution system; enactment of federal excise tax for seasonal influenza vaccines and coverage of quadrivalent influenza vaccines under the Vaccine Injury Compensation Program; reimbursement of vaccines and related services; implementation of H.R. 3590/Pub. L. No. 111-148, the Patient Protection and Affordable Care Act; biologics data exclusivity; clinical trial and testing issues; and, debt and deficit reduction proposals on Medicaid federal funding, Medicaid rebates, and Medicare Part D rebates.
H.R. 2055/Pub. L. No. 112-74 - Consolidated Appropriations Act, 2012, provisions relating to funding for Health and Human Services H.R. 2405/S. 1855 - Pandemic and All-Hazards Preparedness Act Reauthorization, provisions relating to pandemic influenza vaccine development H.R. 4274 - BPCA and PREA Reauthorization Act of 2012 H.R. 2679 - Prematurity Research Expansion and Education for Mothers Who Deliver Infants Early Reauthorization Act, provisions relating to patient safety study and report Issues related to development of legislation reauthorizing the Prescription Drug User Fee Act (PDUFA), including issues relating to approval of biologics, pediatric research incentives, supply chain integrity, drug shortages, and antibiotic incentives; CDC Burden of Disease Study on Respiratory Syncytial Virus (RSV), including RSV prophylaxis; implementation of H.R. 3590/Pub. L. No. 111-148, the Patient Protection and Affordable Care Act; reimbursement of vaccines and related services; Medicaid coverage and reimbursement; biologics data exclusivity; and, debt and deficit reduction proposals on Medicaid federal funding, Medicaid rebates, and Medicare Part D rebates
H.R. 2055/Pub. L. No. 112-74 - Consolidated Appropriations Act, 2012, provisions relating to funding for Health and Human Services H.R. 2405/S. 1855 - Pandemic and All-Hazards Preparedness Act Reauthorization, provisions relating to pandemic influenza vaccine development H.R. 4274 - BPCA and PREA Reauthorization Act of 2012 H.R. 2679 - Prematurity Research Expansion and Education for Mothers Who Deliver Infants Early Reauthorization Act, provisions relating to patient safety study and report Issues related to development of legislation reauthorizing the Prescription Drug User Fee Act (PDUFA), including issues relating to approval of biologics, pediatric research incentives, supply chain integrity, drug shortages, and antibiotic incentives; CDC Burden of Disease Study on Respiratory Syncytial Virus (RSV), including RSV prophylaxis; implementation of H.R. 3590/Pub. L. No. 111-148, the Patient Protection and Affordable Care Act; reimbursement of vaccines and related services; Medicaid coverage and reimbursement; biologics data exclusivity; and, debt and deficit reduction proposals on Medicaid federal funding, Medicaid rebates, and Medicare Part D rebates
To amend the Internal Revenue Code of 1986 to include vaccines against seasonal influenza within the definition of taxable vaccines.
Client: MEDIMMUNE LLC · Firm: MEDIMMUNE, LLC.
H.R. 2405/S. 1855 - Pandemic and All-Hazards Preparedness Act Reauthorization, provisions relating to pandemic influenza vaccine development H.R. 2679/S. 1440 - Prematurity Research Expansion and Education for Mothers Who Deliver Infants Early Reauthorization Act, provisions relating to patient safety study and report H.R. 6687/S. 3176 A bill to amend the Internal Revenue Code of 1986 to include vaccines against seasonal influenza within the definition of taxable vaccines Issues related to Medicaid coverage and reimbursement of biologics; securing the pharmaceutical distribution system through a federal traceability standard; reimbursement of vaccines and related services; implementation of H.R. 3590/Pub. L. No. 111-148, the Patient Protection and Affordable Care Act; biologics data exclusivity; clinical trial and testing issues; and, debt and deficit reduction proposals on Medicaid federal funding, Medicaid rebates, and Medicare Part D rebates.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
MEDIMMUNE LLC via MEDIMMUNE, LLC.
2012 · fourth_quarter · Q4
H.R. 2405/S. 1855 - Pandemic and All-Hazards Preparedness Act Reauthorization, provisions relating to pandemic influenza vaccine development H.R. 2679/S. 1440 - Prematurity Research Expansion and Education for Mothers Who Deliver Infants Early Reauthorization Act, provisions relating to patient safety study and report H.R. 6687/S. 3176 A bill to amend the Internal Revenue Code of 1986 to include vaccines against seasonal influenza within the definition of taxable vaccines Issues related to Medicaid coverage and reimbursement of biologics; securing the pharmaceutical distribution system through a federal traceability standard; reimbursement of vaccines and related services; implementation of H.R. 3590/Pub. L. No. 111-148, the Patient Protection and Affordable Care Act; biologics data exclusivity; clinical trial and testing issues; and, debt and deficit reduction proposals on Medicaid federal funding, Medicaid rebates, and Medicare Part D rebates.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
MEDIMMUNE LLC via MEDIMMUNE, LLC.
2012 · third_quarter · Q3
H.R. 2405/S. 1855 - Pandemic and All-Hazards Preparedness Act Reauthorization, provisions relating to pandemic influenza vaccine development H.R. 2679 - Prematurity Research Expansion and Education for Mothers Who Deliver Infants Early Reauthorization Act, provisions relating to patient safety study and report Issues related to Medicaid coverage and reimbursement of biologics; securing the pharmaceutical distribution system; enactment of federal excise tax for seasonal influenza vaccines and coverage of quadrivalent influenza vaccines under the Vaccine Injury Compensation Program; reimbursement of vaccines and related services; implementation of H.R. 3590/Pub. L. No. 111-148, the Patient Protection and Affordable Care Act; biologics data exclusivity; clinical trial and testing issues; and, debt and deficit reduction proposals on Medicaid federal funding, Medicaid rebates, and Medicare Part D rebates.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
MEDIMMUNE LLC via MEDIMMUNE, LLC.
2012 · second_quarter · Q2
S. 3187/Pub. L. No. 112-144 - Food and Drug Administration Safety and Innovation Act H.R. 2405/S. 1855 - Pandemic and All-Hazards Preparedness Act Reauthorization, provisions relating to pandemic influenza vaccine development H.R. 2679 - Prematurity Research Expansion and Education for Mothers Who Deliver Infants Early Reauthorization Act, provisions relating to patient safety study and report Issues related to securing the pharmaceutical distribution system; enactment of federal excise tax for seasonal influenza vaccines and coverage of quadrivalent influenza vaccines under the Vaccine Injury Compensation Program; reimbursement of vaccines and related services; implementation of H.R. 3590/Pub. L. No. 111-148, the Patient Protection and Affordable Care Act; Medicaid coverage and reimbursement; biologics data exclusivity; and, debt and deficit reduction proposals on Medicaid federal funding, Medicaid rebates, and Medicare Part D rebates.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
MEDIMMUNE LLC via MEDIMMUNE, LLC.
2012 · first_quarter · Q1
H.R. 2055/Pub. L. No. 112-74 - Consolidated Appropriations Act, 2012, provisions relating to funding for Health and Human Services H.R. 2405/S. 1855 - Pandemic and All-Hazards Preparedness Act Reauthorization, provisions relating to pandemic influenza vaccine development H.R. 4274 - BPCA and PREA Reauthorization Act of 2012 H.R. 2679 - Prematurity Research Expansion and Education for Mothers Who Deliver Infants Early Reauthorization Act, provisions relating to patient safety study and report Issues related to development of legislation reauthorizing the Prescription Drug User Fee Act (PDUFA), including issues relating to approval of biologics, pediatric research incentives, supply chain integrity, drug shortages, and antibiotic incentives; CDC Burden of Disease Study on Respiratory Syncytial Virus (RSV), including RSV prophylaxis; implementation of H.R. 3590/Pub. L. No. 111-148, the Patient Protection and Affordable Care Act; reimbursement of vaccines and related services; Medicaid coverage and reimbursement; biologics data exclusivity; and, debt and deficit reduction proposals on Medicaid federal funding, Medicaid rebates, and Medicare Part D rebates
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
MEDIMMUNE LLC via MEDIMMUNE, LLC.
2011 · fourth_quarter · 4A
HR 2055/Pub. L. No. 112-74 - Consolidated Appropriations Act, 2012, provisions relating to funding for Health and Human Services Issues related to CDC Burden of Disease Study on Respiratory Syncytial Virus (RSV), including RSV prophylaxis; vaccine and related services reimbursement; Medicaid reimbursement; health reform implementation; biologics data exclusivity; and, debt and deficit reduction proposals on Medicaid federal funding, Medicaid rebates, and Medicare Part D rebates
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEDIMMUNE LLC via MEDIMMUNE, LLC.
2011 · fourth_quarter · Q4
HR 2055/Pub. L. No. 112-74 - Consolidated Appropriations Act, 2012, provisions relating to funding for Health and Human Services Issues related to CDC Burden of Disease Study on Respiratory Syncytial Virus (RSV), including RSV prophylaxis; vaccine and related services reimbursement; Medicaid reimbursement; health reform implementation; biologics data exclusivity; and, debt and deficit reduction proposals on Medicaid federal funding, Medicaid rebates, and Medicare Part D rebates
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEDIMMUNE LLC via MEDIMMUNE, LLC.
2011 · third_quarter · Q3
CDC Burden of Disease study on RSV, health care reform implementation, Restricted Medicaid Access, Deficit Reduction discussions centering on Part D rebates in Medicare and proposals for a blended Medicaid rate and an increase to the Medicaid Rebate.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEDIMMUNE LLC via MEDIMMUNE, LLC.
2011 · second_quarter · 2A
CDC Burden of Disease study on RSV, Specialty Pharmacy reimbursement, health care reform implementation, IPAB, Restricted Medicaid Access, Deficit Ceiling discussions centering on Part D rebates in Medicare and proposals for a blended Medicaid rate
Filing targets: HOUSE OF REPRESENTATIVES, SENATE